FIELD: medicine, biochemistry, pharmacy.
SUBSTANCE: invention relates to new compounds that represent inhibitors of caspases, in particular, inhibitors of interleukin-1β-converting enzyme and their pharmaceutical compositions. Proposed compounds can be used successfully as agents directed against diseases mediated by interleukin-1, apoptosis and factor inducing interferon-γ or by interferon-γ.
EFFECT: valuable medicinal and biochemical inhibitors.
35 cl
Title | Year | Author | Number |
---|---|---|---|
INHIBITORS OF INTERLEUKIN-1$$$-CONVERTING ENZYME | 1995 |
|
RU2242480C2 |
SUBSTITUTED 2H-PYRAZOLE DERIVATIVE | 2016 |
|
RU2722363C2 |
INTERLEIKYN-1BETA CONVERTING ENZYME INHIBITORS | 1996 |
|
RU2249598C2 |
PYRIDIN-2-YL DERIVATIVES AS IMMUNOMODULATORY AGENTS | 2009 |
|
RU2494099C2 |
MACROCYCLIC PYRIDAZINONE DERIVATIVES | 2014 |
|
RU2660435C2 |
BORON-CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS | 2009 |
|
RU2547441C2 |
TLR7/8 ANTAGONISTS AND THEIR APPLICATION | 2017 |
|
RU2758686C2 |
DIAMINOTRIAZOLES, SUITABLE AS INHIBITORS OF PROTEIN KINASES | 2003 |
|
RU2350606C2 |
BENZOTHIOPHENES AND RELATED COMPOUNDS AS STING AGONISTS | 2019 |
|
RU2806274C2 |
ALKYNYL-SUBSTITUTED HETEROCYCLIC COMPOUND, METHOD FOR PRODUCTION THEREOF AND USE THEREOF IN MEDICINE | 2017 |
|
RU2729069C1 |
Authors
Dates
2006-04-20—Published
1999-03-19—Filed